E ISSN: 2583-049X
logo

International Journal of Advanced Multidisciplinary Research and Studies

Volume 6, Issue 6, 2026

Study of Hypolipidemic Effect of a Polyherbal Compound “Suhridaya” in Preventive Cardiology



Author(s): Dr. Om Prakash Gupta, Dr. Suman Bharali, Dr. G Kumawat, Dr. K Kumari

Abstract:

Ayurveda is the oldest life science and health care system of ancient India. It is valuable for prevention of diseases and their treatment. It is based on Vedic knowledge and has own concepts and philosophy. It is still in clinical practice in Asian countries, mainly in India.

Hriday is described in details through sutras at some texts. Somewhere hriday is described as the heart and somewhere it is described as the brain. Its function i.e. kriya and morphology i.e. swaroop are clearly described as artha and mahat. It is said to be like a lotus bud i.e. pundreek; it is of one’s own fist in size. It is a very vital organ (one of the three specific marmas i.e. trimarma). It is connected with blood carrying channels (rasavaha srotas), with oxygen carrying blood (pranavaha srotas), it is mentioned as the seat of chetana i.e. consciousness (manovaha srota), it is also said to be the place of para ojus (the atriopeptide which is vital and immune regulatory,) and it is responsible for circulation of oxygen loaded blood to entire body including heart itself.

The vatic hriroga which may be correlated with ischemic heart disease (cardiovascular disease) are common in young and obese population of our country. It is associated with dyslipidemia due to various factors and co-factors. A clinical study was done from January 2025 to June 2025 with an herbal compound, which has hypolipidemic effect and acts as a cardiac tonic. The trial drug ‘Suhridaya’ consists of eight well documented herbs viz. arjuna, aswagandha, amalaki, punarnava, gokshura, pushkar mula, jatamanshi and haritaki. These herbs have established hypolipidemic and antihypertensive effects.

For the study, 100 patient were randomly selected having dyslipidemia and who had risk of developing cardiac disease. They were given the trial drug in the dose of 1gm twice daily after meal for three months. The data was collected before, during and after the study and analyzed statistically. Significant reduction in serum cholesterol and serum triglycerides was observed at the end of the study.


Keywords: Cardiovascular Disease, Dyslipidemia, Hridroga, Cholesterol, Triglycerides, Para Ojus, Atrio-peptide

Pages: 610-613

Download Full Article: Click Here